Skin cancer detection using image fusion and feature aggregation strategies has rapidly advanced and become a cornerstone of state-of-the-art computer-aided diagnosis systems, particularly in dermoscopic image analysis. The complexity of skin lesion detection—owing to factors like intra-class variability, inter-class similarity, and the presence of image artifacts—presents significant challenges that are effectively addressed through the fusion of diverse data, features, and model outputs. Here, we critically analyze methodological trends, technical advances, and empirical findings in this domain, drawing upon recent literature and benchmarking results.
Image-Level FusionImage-level or data-level fusion focuses on combining raw or preprocessed images from multiple modalities or sources prior to feature extraction. The rationale is to harness complementary information that different imaging modalities (like RGB, multispectral, clinical, or synthetic GAN-generated images) offer for richer lesion representation. For example, generated images using StyleGANs have been fused with real dermoscopy data to mitigate dataset imbalance and improve the feature diversity accessible to learning-based classifiers, thus enhancing model robustness and generalizability for dermoscopy image classification [1]. Such strategies, while effective in maximizing visual cues, require careful spatial alignment and quality control to prevent noise amplification or the propagation of imaging artifacts.
Feature-Level Fusion and AggregationFeature-level fusion and aggregation are arguably the most prevalent and effective strategies in current skin cancer detection research. These methods involve the extraction of features from multiple sources—whether different layers within a single CNN, multiple CNN architectures, or a combination of handcrafted and deep features—and then their aggregation into a unified representation for classification or segmentation tasks.
A notable advancement involves fusion of deep features extracted from distinct CNN backbones (e.g., ResNet, NASNet, EfficientNet), leveraging transfer learning and pre-trained models to augment limited medical datasets. Mahbod et al., for instance, aggregated multi-network features using principal component analysis and concatenation, followed by SVM classification, resulting in accuracy gains across public skin cancer datasets [2]. Hybrid fusion approaches have similarly combined handcrafted features (such as texture characteristics from LBP or Haralick patterns) with deep features, further enhancing discriminatory power in challenging diagnostic settings [2][3].
Attention-based mechanisms have raised feature fusion to a new level of adaptivity. By dynamically assigning weights to features across channels or spatial regions, attention modules such as CBAM or SENet enable networks to emphasize pathologically significant areas and suppress irrelevant background or noise [4]. Recent architectures also integrate multi-scale and bi-directional feature learning to amplify lesion-boundary cues and maintain consistency across diverse image scales, with consistent gains in both accuracy and interpretability noted for segmentation and classification [4].
Decision-Level (Score-Level) FusionDecision-level or late fusion strategies combine outputs from multiple classifiers, each of which may be trained on different input types, feature sets, or even distinct model architectures. Methods such as majority voting, weighted averaging, or meta-ensemble stacking have been effective in improving generalization and balancing accuracy, particularly in multi-class settings for diseases such as melanoma, basal cell carcinoma, and nevus [1][2]. For example, decision fusion architectures that combine the predictions from several CNNs have outperformed individual models in the ISIC 2019 skin cancer challenge, with accuracy improvements attributed to the reduction in model-specific errors and biases [1][2].
Advanced Fusion Architectures and ExplainabilityFusion strategies increasingly leverage architectural innovations from adjacent fields—such as hyperspectral imaging and industrial defect detection—to address domain-specific challenges in dermatology. The adoption of multi-stream networks, pyramid feature fusion, and global context modules (analogous to PGA-Net and feature pyramid networks in other domains) enables the simultaneous capture of fine-grained local features and high-level global context, which is critical for accurate lesion boundary delineation [4][5][6].
Interpretability also remains a focal point in recent work, with attention and feature-aggregation mechanisms employed not only for performance but also for enhancing model explainability—allowing clinicians to visualize which features or regions drive specific diagnostic outcomes [4].
Empirical Results and BenchmarksFusion-based skin cancer analysis methods have consistently demonstrated superior performance. State-of-the-art studies report classification and segmentation accuracies exceeding 90–94% on prominent dermoscopy datasets (ISIC, PH2, HAM10000), even with lightweight or ensemble architectures, as consolidated in the following table:
Key Challenges and OutlookWhile fusion methods yield clear gains, challenges persist—class imbalance, data heterogeneity, interpretability, and computational cost remain pressing issues [2][3][4]. Emerging directions include lightweight multi-stream fusion for mobile diagnosis [2], robust attention-guided fusion for explainable AI [4][6], and transformer-based approaches for unified long-range feature integration [3].
In summary, image fusion and feature aggregation—at both data and model levels—represent proven and versatile solutions for automatic skin cancer detection. These methods, particularly when coupled with attention, multi-scale, and ensemble frameworks, underpin robust, interpretable, and clinically relevant diagnostic pipelines [1][2][3][4].